Andean Precious Metals (CVE:APM) Shares Down 8% – What’s Next?

Shares of Andean Precious Metals Corp. (CVE:APM) dropped 8% during trading on Tuesday . The company traded as low as C$1.12 and last traded at C$1.15. Approximately 461,849 shares were traded during trading, an increase of 139% from the average daily volume of 193,266 shares. The stock had previously closed at C$1.25.

Analyst Upgrades and Downgrades

Separately, Desjardins raised shares of Andean Precious Metals to a “moderate buy” rating in a research note on Thursday, October 31st.

Andean Precious Metals Price Performance

The business’s 50 day simple moving average is C$1.46 and its 200 day simple moving average is C$1.25. The company has a market capitalization of C$165.79 million, a PE ratio of 2.92 and a beta of 1.22.

Insider Activity

In other Andean Precious Metals news, insider 2176423 Ontario Ltd. acquired 84,400 shares of the business’s stock in a transaction that occurred on Tuesday, October 8th. The stock was purchased at an average cost of C$1.51 per share, with a total value of C$127,359.60. In the last 90 days, insiders have bought 306,200 shares of company stock valued at $432,953. 69.37% of the stock is currently owned by company insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.